July 2026

RHEUMATOLOGY

GLP-1S AND BEYOND IN RHEUMATOLOGY CARE

At the 2026 Rheumatology Winter Clinical Symposium, Eric Ruderman, MD, discussed the connection between obesity, cardiometabolic risk and systemic inflammation.

Dr. Ruderman covers:
  • Why metabolic health is becoming a larger focus in rheumatoid arthritis and psoriatic arthritis care
  • How GLP-1 therapies are influencing conversations about treatment and disease management
  • The relationship between obesity, systemic inflammation and cardiometabolic risk in rheumatic disease
  • What evolving evidence may mean for future clinical decision-making
Eric M. Ruderman, MD, Professor of Rheumatology at Northwestern Medicine​

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like